Understanding the mechanisms leading to the disruption of the architecture of lymphoid organs early during viral infections in mice and how MyD88 or NK cell responses can prevent this process could open novel avenues to treat viral infections in humans. This evidence concerns the gene MYD88 and viral infectious disease.